Cryo-Cell International Inc
NASDAQ:CCEL
Intrinsic Value
Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. [ Read More ]
The intrinsic value of one
CCEL
stock under the Base Case scenario is
4.25
USD.
Compared to the current market price of 9.38 USD,
Cryo-Cell International Inc
is
Overvalued by 55%.
Cryo-Cell International Inc's market capitalization is 77.8m USD.
CCEL stock price is 9.38 USD.
CCEL stock (4.25 USD) is 55% less than its price (9.38 USD).
CCEL stock (6.73 USD) is 28% less than its price (9.38 USD). Open Relative Valuation
CCEL has downside potential of 2% compared to the average analyst price target.
Open Wall St Estimates
CCEL's Revenue has grown by 2% over the past 12 months.
CCEL's Revenue has been growing by 1% per year for the last 3 years.
CCEL has negative Operating Income for the last twelve months.
CCEL's Revenue is forecast to grow at a rate of 5% per year over the next 3 years.
CCEL has negative Net Income for the last twelve months.
CCEL's long-term liabilties (72m USD) exceed its long-term assets (62m USD).
CCEL has positive three-year average ROIC (Return on Invested Capital): 5%. The company is efficient at using invested capital to generate operating income.
CCEL has negative Free Cash Flow for the last twelve months.
CCEL's ROE (Return on Equity) has significantly increased in the last 3 years from -94% to 177%.
CCEL's ROIC (Return on Invested Capital) has significantly decreased in the last 3 years from 7% to -16%.
CCEL's ROIC (Return on Invested Capital) for the past 12 months is negative and is equal to -16%.
CCEL's ROE (Return on Equity) for the past 12 months is very high and is equal to 177%.
CCEL's short-term liabilties (19m USD) exceed its short-term assets (9m USD).
CCEL has positive Gross Profit for the last twelve months.
CCEL has positive Net Debt. This means that the company has more debt (8m USD) than cash and short-term investments (980k USD).
CCEL has very high three-year average ROE (Return on Equity): 105%. The company is very efficient at transforming stockholders' equity into net income.
CCEL's D/E (Debt to Equity) is very low and is equal to -0.81.
CCEL's Altman Z-Score is very low and is equal to -0.74.
Valuation Backtest
Cryo-Cell International Inc
Run backtest to discover the historical profit from buying and selling
CCEL
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Cryo-Cell International Inc
Balance Sheet Decomposition
Cryo-Cell International Inc
| Current Assets | 9.5m |
| Cash & Short-Term Investments | 979.6k |
| Receivables | 6.7m |
| Other Current Assets | 1.7m |
| Non-Current Assets | 52.3m |
| Long-Term Investments | 308k |
| PP&E | 22.6m |
| Intangibles | 2.9m |
| Other Non-Current Assets | 26.5m |
| Current Liabilities | 19.4m |
| Accounts Payable | 3m |
| Accrued Liabilities | 4.2m |
| Other Current Liabilities | 12.2m |
| Non-Current Liabilities | 52.7m |
| Long-Term Debt | 8.4m |
| Other Non-Current Liabilities | 44.3m |
Earnings Waterfall
Cryo-Cell International Inc
|
Revenue
|
31.4m
USD
|
|
Cost of Revenue
|
-8.5m
USD
|
|
Gross Profit
|
22.8m
USD
|
|
Operating Expenses
|
-36m
USD
|
|
Operating Income
|
-13.2m
USD
|
|
Other Expenses
|
3.4m
USD
|
|
Net Income
|
-9.7m
USD
|
Free Cash Flow Analysis
Cryo-Cell International Inc
CCEL Profitability Score
Profitability Due Diligence
Cryo-Cell International Inc's profitability score is 61/100. The higher the profitability score, the more profitable the company is.
Score
Cryo-Cell International Inc's profitability score is 61/100. The higher the profitability score, the more profitable the company is.
CCEL Solvency Score
Solvency Due Diligence
Cryo-Cell International Inc's solvency score is 37/100. The higher the solvency score, the more solvent the company is.
Score
Cryo-Cell International Inc's solvency score is 37/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CCEL Price Targets Summary
Cryo-Cell International Inc
According to Wall Street analysts, the average 1-year price target for
CCEL
is 9.18 USD
with a low forecast of 9.09 USD and a high forecast of 9.45 USD.
Ownership
CCEL Insider Trading
Buy and sell transactions by insiders
| Period | Sold | Bought | Net |
|---|---|---|---|
| 3 Months |
|
|
|
| 6 Months |
|
|
|
| 9 Months |
|
|
|
| 12 Months |
|
|
|
Shareholder Return
CCEL Price
Cryo-Cell International Inc
| Average Annual Return | 1.19% |
| Standard Deviation of Annual Returns | 46.48% |
| Max Drawdown | -76% |
| Market Capitalization | 77.8m USD |
| Shares Outstanding | 8 290 000 |
| Percentage of Shares Shorted | 0.3% |
Company Profile
Cryo-Cell International Inc
Country
Industry
Market Cap
Dividend Yield
Description
Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. The company is headquartered in Oldsmar, Florida and currently employs 83 full-time employees. The firm operates through three segments: The cellular processing and cryogenic storage of umbilical cord blood and cord tissue stem cells for family use; the manufacture of PrepaCyte CB units, the processing technology used to process umbilical cord blood stem cells, and the cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives and other related healthcare professionals. The Company, in combination with its global affiliates, stores approximately 500,000 cord blood and cord tissue specimens around the world for the benefit of newborn babies and possibly other members of their families. Its processing and storage of specimens is handled from its facility in Oldsmar, Florida.
Contact
IPO
Employees
Officers
The intrinsic value of one
CCEL
stock under the Base Case scenario is
4.25
USD.
Compared to the current market price of 9.38 USD,
Cryo-Cell International Inc
is
Overvalued by 55%.
You don't have any saved screeners yet
